Cargando…

Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1

Myotonic dystrophy type 1 (DM1) is caused by CTG-repeat expansions leading to a complex pathology with a multisystemic phenotype that primarily affects the muscles and brain. Despite a multitude of information, especially on the alternative splicing of several genes involved in the pathology, inform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todorow, Vanessa, Hintze, Stefan, Kerr, Alastair R. W., Hehr, Andreas, Schoser, Benedikt, Meinke, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395314/ https://www.ncbi.nlm.nih.gov/pubmed/34445314 http://dx.doi.org/10.3390/ijms22168607

Ejemplares similares

Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle
por: Todorow, Vanessa, et al.
Publicado: (2023)

Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)

CTG-Repeat Detection in Primary Human Myoblasts of Myotonic Dystrophy Type 1
por: Hintze, Stefan, et al.
Publicado: (2021)

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
por: Hintze, Stefan, et al.
Publicado: (2018)

Nuclear Small Dystrophin Isoforms during Muscle Differentiation
por: Donandt, Tina, et al.
Publicado: (2023)

Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees
por: de las Heras, Jose I, et al.
Publicado: (2022)

Isolation and Characterization of Primary DMD Pig Muscle Cells as an In Vitro Model for Preclinical Research on Duchenne Muscular Dystrophy
por: Donandt, Tina, et al.
Publicado: (2022)

Core Clinical Phenotypes in Myotonic Dystrophies
por: Wenninger, Stephan, et al.
Publicado: (2018)

Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
por: Schoser, Benedikt, et al.
Publicado: (2010)

Editorial: Beyond Borders: Myotonic Dystrophies–A European Perception
por: Schoser, Benedikt, et al.
Publicado: (2018)

Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
por: Montagnese, Federica, et al.
Publicado: (2020)

Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease
por: Hintze, Stefan, et al.
Publicado: (2020)

Consensus-based care recommendations for adults with myotonic dystrophy type 2
por: Schoser, Benedikt, et al.
Publicado: (2019)

Degeneration of muscle spindles in a murine model of Pompe disease
por: Watkins, Bridgette, et al.
Publicado: (2023)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort
por: Cumming, Sarah A., et al.
Publicado: (2019)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis
por: Gutschmidt, K., et al.
Publicado: (2020)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1
por: Wenninger, Stephan, et al.
Publicado: (2021)

Transcriptome alterations in myotonic dystrophy frontal cortex
por: Otero, Brittney A., et al.
Publicado: (2021)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Noninvasive assessment of respiratory muscle strength and activity in Myotonic dystrophy
por: Evangelista, Morgana de Araújo, et al.
Publicado: (2017)

Exploration of mitochondrial defects in sarcopenic hip fracture patients
por: Hintze, Stefan, et al.
Publicado: (2022)

Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1
por: Davey, Emily E., et al.
Publicado: (2023)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Affection of the Gastrointestinal Smooth Muscles in Myotonic Dystrophy Is Not Unusual
por: Finsterer, Josef, et al.
Publicado: (2019)

Ultrasonography of abdominal muscles: Differential diagnosis of late-onset Pompe disease and myotonic dystrophy type 1
por: Hsieh, Pei-Chen, et al.
Publicado: (2022)

Premature Senescence in Primary Muscle Cultures of Myotonic Dystrophy Type 2 is not Associated with p16 Induction
por: Renna, L.V., et al.
Publicado: (2014)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mahadevan, Mani S., et al.
Publicado: (2021)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Towards the Identification of Biomarkers for Muscle Function Improvement in Myotonic Dystrophy Type 1
por: Aoussim, Amira, et al.
Publicado: (2023)

Uptake of moss‐derived human recombinant GAA in Gaa (−/−) mice
por: Hintze, Stefan, et al.
Publicado: (2021)

Consensus-based care recommendations for adults with myotonic dystrophy type 1
por: Ashizawa, Tetsuo, et al.
Publicado: (2018)

Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates
por: Winblad, Stefan, et al.
Publicado: (2010)

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1
por: Winkler, Nelson S., et al.
Publicado: (2018)

I-18 Chronic muscle electrical stimulation in Myotonic Dystrophy
por: Chisari, C.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8mfcia8ctqretq9pcpt2br8i0m